Helicobacter pylori is the causative agent of chronic gastritis and peptic ulceration in humans. Acquisition of this organism early in a person's life also predisposes for later development of gastric cancer [1] [2] [3] [4] . Urease expression and motility permit these bacteria to survive transiently in an acid environment and to penetrate the mucous layer [5] . H. pylori is usually located within the thick mucous layer in close proximity to gastric epithelial cells and is believed to recognize specific epithelial cell receptors [6] . In primary gastric epithelial cells and cultured cell lines, bacterial adherence is frequently associated with socalled pedestal formation, indicative of actin polymerization beneath the attached microbe in the host cell, as has been shown for enteropathogenic Escherichia coli [7] [8] [9] .
Several candidate molecules have been proposed as receptors for H. pylori adherence, such as N-acetylneuraminyllactose, GM3 ganglioside, sulfatides, phosphatidylethanolamine, laminin, and the Lewis b (Le b ) blood group antigen [10] [11] [12] [13] [14] [15] [16] [17] . In an in situ adherence assay, using formalin-fixed normal human gastric tissue, only Le b -specific binding was noted. Thus, H. pylori attached to fixed human gastric surface epithelial cells expressing Le b , whereas gastric tissue lacking Le b expression did not bind H. pylori [16] . The generation by Falk et al. [18] antigen-binding activity [19] . However, the ability of this mutant to bind to gastric cells has not been reported. Mutants of H. pylori defective in adhesion to the gastric cell line Kato III have been isolated [20] , but the cellular receptor was not described. A role for fucosylated blood group antigens as a central part of the infectious process has been questioned because adherence of H. pylori to cultured Kato III cells and to primary gastric cells was not affected by the expression levels of Le a and Le b and was not inhibited by anti-Le a or anti-Le b antibodies [21] . Recently, it was also demonstrated that bacterial binding to Le b is mainly seen in type I isolates [19] . Therefore, expression of Le b binding might not be required for bacterial colonization of the stomach but rather might play a role in pathogenesis. The H. pylori adhesins and corresponding receptors involved in binding to cultured gastric cells and primary gastric cells remain unknown.
A currently accepted model is that chronic active gastritis may progress to atrophic gastritis with metaplasia, dysplasia, and eventually, neoplasia. Epidemiologic data suggest that it is primarily cag-positive H. pylori strains (type I strains) that increase the risk for gastric cancer [22] . Such strains contain a 40-kb large, so-called pathogenicity island, which encodes a series of proteins that are thought to be involved in the secretion of proteins, some of which are believed to activate interleukin-8 expression [23, 24] . Most type I strains also express a vacuolating cytotoxin encoded by the vacA gene, which is thought to play a role in the etiology of peptic ulcer disease [5] . A role for the toxin in transmembrane signaling has also been proposed [25] .
It has recently become apparent that several pathogenic bac- 
NOTE. ADU, adult, duodenal ulcer; DS, dyspeptic syndrome; AT, asymptomatic; CDU, child, duodenal ulcer; CIC, child, chronic gastritis. Cytotoxin expression in HeLa cells was determined as previously described [29] . HA, hemagglutination of human erythrocytes. Le b binding was tested using filter-binding assay with Le b -human serum albumin [29] . a cag pathogenicity island was probed by polymerase chain reaction using primers specific for cagA and cagE [29] .
teria may affect target cells to enhance adherence. For example, when enteropathogenic E. coli are allowed to interact with host cells, a phosphorylated 90-kDa protein is found in the host cell membrane that acts as a receptor for bacterial intimin, leading to amplified adherence [26] . This receptor was recently shown to be a bacterial protein delivered to the host cells through a type III secretion system [27] .
Since in situ binding of H. pylori to target tissue will not reveal adherence influenced by signaling to host cells, we decided to make a comparison between bacterial binding to fixed gastric tissue and to viable and fixed cell lines. Target expression of Le b and the corresponding bacterial adhesin were both required for in situ adherence to fixed normal or pathologic gastric tissue but not for increased adherence to cultured cells. Thus, significant adherence occurred to all tested cell lines, even those containing no or only low levels of Le b . Type I strains of H. pylori bound significantly better to viable cultured cells than to fixed ones, and de novo bacterial and eukaryotic protein synthesis were required for increased adherence. Such requirements were not found for type II strains, suggesting that adherence of pathogenic H. pylori to cultured cells is a much more dynamic process than previously thought.
Materials and Methods
Bacterial strains and culture conditions. The H. pylori strain A5 was isolated from a patient with gastric ulcer [28] , whereas H. pylori P466 was isolated from a patient with acute gastritis [16] . Both strains are cag-and cytotoxin-positive, and both can adhere in situ to fixed gastric tissue, an adherence that can be inhibited by Le b conjugated to human serum albumin (HSA). In addition, strain A5, unlike P466, expresses a hemagglutinin, inhibitable by sialylated glycoconjugates such as fetuin. H. pylori MO19 was isolated from an asymptomatic patient and is both cag-and cytotoxinnegative. It possesses a hemagglutinin but cannot adhere in situ to gastric tissue [16] . Two new clinical isolates from children, 584-95, a type I, and 667-95, a type II [29] , were also included in this study (table 1) . Bacteria were grown on brain-heart infusion agar containing 10% horse blood, isovitalex (1%), vancomycin (10 mg/mL), amphotericin B (4 mg/mL), and trimethoprim (5 mg/mL). Cultures were incubated in 5%-7% carbon dioxide, 5% hydrogen, and 88%-90% nitrogen at 37ЊC. The bacteria were grown on plates for 2-5 days. Quantitation of bacteria in suspension was made by optical density measurements.
Tissue samples. Two biopsies per person, one from antrum and the other from corpus, were taken from patients with different underlying gastric diseases. Three gastrectomy specimens came from gastric neoplasia patients. Two stomach samples from 2 persons contained intestinal metaplasia. All tissues were fixed, embedded, and cut in 4-mm sections. One section from each tissue was stained with hematoxylin-eosin. Serial sections from the same area in each tissue were used for antigen staining or in situ bacterial adherence assays.
Cell lines and culture conditions. The following human cell lines were used: AGS (ATCC CRL 1739, gastric adenocarcinoma); Kato III (ATCC HIB 103, gastric carcinoma); SW620 (ATCC CCL 227, human colon adenocarcinoma, lymph node metastasis); A431 (ATCC CRL 1555, human epidermoid carcinoma); ME180 (ATCC HTB33, an epithelial-like cell line derived from a human cervical carcinoma); and HeLa (ATCC CCL2 epithelioid cervical cell line). Other cell lines included the following: COS-1 (fibroblast-like from African monkey kidney) cells and CHO cells. All cells were grown in tissue culture medium according to the instruction of the deliverer and cultured at 37ЊC in 5% CO 2 .
Antibodies. Monoclonal antibodies to human Le a and Le b blood group antigens were obtained from Immucor (Norcross, GA). Goat anti-mouse or anti-rabbit IgG F(ab) 2 fragments were conjugated separately with tetramethyl-rhodamine isothiocyanate (TRITC) or FITC, all from Boehringer Mannheim (Mannheim, Germany). Rabbit polyclonal anti-H. pylori antibody against whole heat-killed bacteria was purchased from DAKO (Glostrup, Denmark).
Adherence assay. The in situ adherence assay has been described in detail [16] . Briefly, sections of paraffin-embedded tissue were deparaffinized in xylene and isopropanol, rinsed in water followed by PBS, and then incubated for 1 h in blocking buffer (1.5% bovine serum albumin in PBS). The bacteria were grown on plates for 3-5 days, labeled with FITC, and suspended in blocking buffer to an . The tissue sections were overlaid with FITC-A ϭ 0.05 600 labeled H. pylori (green to yellow) and incubated for 1 h at room temperature in the dark, and free bacteria were washed away with PBS by six to eight rinses prior to inspection. This staining procedure also results in some autofluorescence of the gastric tissue.
The adherence of H. pylori to cultured cells was determined basically as previously described [30] . Briefly, cells were grown in chamberslide 8 (Lab-Tek; Nunc, Naperville, IL) for 1 or 2 days at 37ЊC in 5% CO 2 , until 80% confluence was reached. H. pylori were grown on plates for 2 days, diluted in Ham F12 medium without any antibiotics, and then added to cultured cells. The cells were washed with PBS and incubated with H. pylori for 30 min. The ratio of added bacteria to cells was ∼100:1. The free bacteria were washed away with PBS or with 15% sucrose solution (vol/vol) for Kato III cells. A 10-min treatment with 10% formalin in PBS was used to fix bacteria or cultured cells. To block bacterial protein synthesis, the bacteria were incubated with 25 mg/mL chloramphenicol for 30 min and then overlaid on a viable cell monolayer for an additional 30 min. For inhibition of cytoplasmic eukaryotic protein synthesis, we pretreated AGS cells with cycloheximide (Sigma, St. Louis) at different concentrations for 1 h at 37ЊC in a cell incubator, then overlaid with H. pylori for an additional hour. After washing away free bacteria, the bacteria were stained with anti-H. pylori whole bacterial antibody (1:100) for 30 min. The bacteria were visualized by adding goat anti-rabbit IgGconjugated FITC (1:100) antibody.
Flow cytometry. Flow cytometry was done as described by Dunn et al. [30] . Briefly, H. pylori were cultured for 3 days on plates and then washed once with PBS. AGS cells and Kato III cells were grown for 24 h and then cocultured with bacteria for 30 min; the ratio of added bacteria to cells was ∼200:1. The bacteria were visualized by adding anti-H. pylori antibody, followed by FITC-conjugated anti-rabbit antibody. In inhibition experiments, the bacteria were pretreated with Le b conjugated to HSA at 20-200 mg/mL or with fetuin at 100-200 mg/mL for 1 h before being added to the cells. HSA was used as a negative control. An H. pylori suspension was then added for an additional 30 min. Unbound bacteria were washed away with 15% sucrose in PBS, followed by four to six rinses in PBS. To detect the Lewis antigen expression on the surface of the cells, the primary antibodies against Lewis antigens were applied to the cells for 30 min on ice, and then the cells were washed three times with PBS. Goat anti-mouse IgG F(ab) 2 fragment conjugated with TRITC was used as secondary antibody. After being stained, the cells were treated with 1% formaldehyde in PBS and analyzed within 3 days on a FACScan flow cytometer (Becton Dickinson, Mountain View, CA). Bacteria and cells without label and mouse IgG were used as negative controls. Using a dot-plot display of forward and right angle scatter, the analysis was made on single cells, and most cell debris, clumps of cells, and nonadherent bacteria were excluded. In total, 10,000 gated events were collected, and data were analyzed using the Lysis software program (Becton Dickinson).
Immunohistochemical techniques. Embedded tissue sections were deparaffinized, rinsed in water, and then rinsed in PBS (pH 7.4). Le b oligosaccharide antigen was detected with primary antibodies, then the tissue sections and cells were washed three times with 0.03% Triton-X 100 in PBS. Antigen-antibody complexes were visualized with goat anti-mouse IgG F(ab) 2 conjugated with TRITC (giving a red color), and the result was read by use of a fluorescence microscope.
Statistical analysis. Results are expressed as the mean ‫ע‬ SD of at least three experiments. Student's t test was used to assess the significance of differences between means in binding and inhibition assays. (table 1) .
Results

Attachment of H. pylori to fixed human gastric tissue requires bacterial expression of the
We also tested 2 isolates from children. Strain 584-95, a type I strain that in a filter-binding assay was Le b -binding-positive [29] , adhered to gastric tissue in the in situ adherence assay, but significantly less than did A5. Strain 667-95, a type II isolate that in a filter-binding assay was Le b adhesin-negative, could not adhere to fixed gastric tissue [29] .
To further explore the relation between H. pylori in situ adherence and Le b expression, we obtained a tissue from a gastrectomy specimen that contained the junction between antrum and duodenum. Both the gastric and duodenal parts of this tissue section were Le b -positive ( figure 1D, 1E) . Nevertheless, FITC-labeled A5 bound only to the gastric part ( figure 1F, 1G ). This means either that the Le b epitope is inaccessible in the duodenal region of this individual or that in situ adherence to fixed tissue requires one or more additional factor(s) besides the Le b carbohydrate epitope. Two persons with intestinal metaplasia were also included in this study. One tissue was Le b -positive, and in situ H. pylori A5 binding was good, even to the intestinal metaplastic cells figure  2B, 2C) . It therefore appears that Le b expression can vary markedly in intestinal metaplasia, and as a consequence, bacterial in situ binding.
In tissue samples from 3 patients with gastric neoplasia, the normal pattern of Le b expression was broken up. However, in situ adherence of H. pylori FITC-labeled A5 occurred preferentially to the Le b -positive patches in the neoplasia, as exemplified for two gastric cancers ( figures 1J, 1K, 2D-2F) .
Taken together, the in situ adherence data clearly support previous work [16] . Since strain A5 also expresses a hemagglutinin inhibitable by fetuin, we used flow cytometry to see whether fetuin could inhibit adherence of A5 bacteria to Kato III cells. Only a very high concentration of fetuin (200 mg/mL) gave rise to a modest inhibition of binding, as was also the case for HSA ( figure 2C) .
Efficient adherence of type I strains to cultured AGS cells requires viable target cells as well as viable bacteria, both having active protein synthesis.
In the cell culture experiments, bacteria were visualized by adding rabbit anti-H. pylori antibody, followed by goat anti-rabbit IgG conjugated with FITC, that is, intact viable bacteria were allowed to interact with viable cells. This is in contrast to the previous in situ adherence studies, in which bacteria were conjugated with FITC prior to adherence, and the gastric tissue was fixed by formalin [16] . To understand the major difference between the adherence of H. pylori to fixed gastric tissue and viable cells, we fixed either AGS cells or bacteria before the bacteria were allowed to infect the cells (figures 4 and 5). The adherence of 3 type I strains of H. pylori (A5, P466, and 584-95) was significantly more prominent to viable AGS cells than to formalin-fixed cells ( figure 4) . Bacterial binding to viable cells was confined to the peripheral border of the cells, not readily apparent in figure 5 because staining was taken up mainly by the nucleus, but evident using phase-contrast microscopy (data not shown). This result suggests an asymmetric distribution of the receptor (figure 5). The type II H. pylori MO19 and 667-95 strains, unable to adhere in situ to fixed Le b -positive gastric tissue, both adhered to cultured gastric cells, albeit at a slightly lower level than type I strains (table 3) . Of interest, adherence of the 2 type II strains to AGS cells was only slightly decreased when cells were formalin-fixed (figure 4).
Efficient adherence of the 3 type I strains to cultured AGS cells required viable target cells and bacteria with intact protein synthesis. Inhibition of bacterial protein synthesis with 25 mg/ mL chloramphenicol in all three cases drastically reduced binding to viable AGS cells (figure 4). Type II strains did not require active protein synthesis for efficient adherence to AGS cells. Formalin-fixed bacteria in all cases bound poorly, and when bacteria and AGS cells were both fixed, a very low residual binding was seen for both type I and type II strains (figure 4).
Cycloheximide at different concentrations was used to inhibit cytosolic protein synthesis in AGS cells for 1 h prior to the addition of bacteria. Cycloheximide at 50 mg/mL reduced A5 adherence by 3-fold, whereas binding of the type II strain MO19 was only reduced by ∼40% ( figure 6 ). Thus, optimal adherence of the type I strain A5 involves a modulation of the host cell that requires de novo protein synthesis.
Discussion
In this paper, we confirm our previous findings [16] that adherence of H. pylori to formalin-fixed normal human gastric tissue is dependent on the expression of the Le b oligosaccharide in the tissue and on the ability of the FITC-labeled microbe to express one or more adhesins, presumably BabA, recognizing this epitope [19] . The present study showed that adherence of H. pylori in the in situ tissue binding assay occurred not only to normal surface mucous cells but also to metaplastic cells and to gastric neoplasia, provided Le b was expressed. In only one case did we not observe expression of the Le suggesting that the terminal fucose on Le b needs to be fully exposed for interaction with the bacterial adhesin. It is, however, also possible that bacterial in situ adherence to fixed tissue requires an additional component not expressed in the duodenal tissue of the studied person. Such an explanation would, however, be contradicted by the finding that H. pylori can bind directly to immobilized Le b -HSA without any additional factors [17] . H. pylori is normally not found in the duodenum, except in cases of gastric metaplasia [31] . It was recently demonstrated that a gastric metaplasia polyp in the duodenum underwent resolution after eradication of H. pylori found to be associated with the polyp [32] . Therefore, it will be important to find out whether or not the ability of H. pylori to colonize gastric tissue in duodenum involves bacterial binding to the Le b epitope. In the in situ adherence assay, H. pylori strain A5 did bind to intestinal metaplasia. In biopsies, H. pylori is rarely found associated with the epithelium in areas of intestinal metaplasia [33] . However, Genta et al. [34] recently found H. pylori in intimate contact with intestinal metaplasia in 32 patients. In posttreatment biopsy specimens from 4 patients whose infection was not cured, H. pylori persisted in intestinal metaplasia [34] . It is possible that bacterial binding to intestinal metaplasia may facilitate the progression to dysplasia and to carcinoma. Therefore, it could be important to find out whether the observed variance in bacterial adherence to intestinal epithelium in vivo relates to variant expression of Le b in metaplasia or variant bacterial expression of a Le b -binding BabA adhesin. If our finding of increased adherence for viable cultured cells can be extrapolated to epithelial cells in intact tissues, it may well be that certain cell types can respond to H. pylori by up-regulating surface receptors, whereas others may not.
Our recent studies in children suggest that Le b -negative H. pylori strains can persistently colonize the gastric mucosa. In biopsies from these children, bacteria were seen in close proximity to the gastric mucosa [29] . Therefore, in the intact in vivo system, even Le b -binding-negative strains might be able to bind to the gastric mucosa. It has been calculated that some adherence (1%-5%) of H. pylori is required for persistent colonization [35] . The finding that Le b binding was restricted to type I strains, known to be associated with both peptic ulcer disease and gastric cancer, suggests that Le b binding might be a pathogenicity factor rather than a property required for colonization. It was interesting to note that all 3 type I strains carrying the cag-region and expressing vacuolating cytotoxin bound considerably better to viable AGS cells than to fixed ones, whereas adherence of the 2 type II strains was much less affected by fixation. Since pretreatment of AGS cells with cycloheximide significantly reduced adherence of the type I strain A5 while having only a small effect on MO19 binding, a type II strain, we suggest that pathogenic H. pylori (type I) interacts with cultured gastric cells in such a way that host surface receptors are up-regulated through a process requiring de novo protein synthesis. Further data indicate that optimal adherence for type I H. pylori requires a phosphotyrosine signaling cascade (unpublished data). The actual adhesin(s) on the microbe and its corresponding receptor on the viable target cell are currently unknown.
Our data suggest that Le b -independent binding to cultured cells requires active bacterial protein synthesis. It has recently been demonstrated that H. pylori may activate signal transduction pathways [36, 37] and that gene products from the cag pathogenicity island participate in the signaling process. It has also been demonstrated that purified vacuolating cytotoxin affects Ca ϩϩ , cyclic AMP, and inositol phosphate levels [25] . Since adherence of type II strains was marginally affected by inhibition of bacterial protein synthesis, we suggest that one or more secreted gene products from the cag-region and/or the vacuolar cytotoxin contribute to the phenomenon of increased adherence seen in type I strains. A study on adherence making use of specific cag-region and vacA mutants has therefore been initiated.
